Nuvasive Inc  (NUVA)
Other Ticker:  
Price: $39.7500 $-0.91 -2.238%
Day's High: $41 Week Perf: 1.48 %
Day's Low: $ 39.51 30 Day Perf: -3.87 %
Volume (M): 31,369 52 Wk High: $ 44.52
Volume (M$): $ 1,246,898 52 Wk Avg: $40.66
Open: $40.62 52 Wk Low: $36.22

 Market Capitalization (Millions $) 2,103
 Shares Outstanding (Millions) 53
 Employees 4,900
 Revenues (TTM) (Millions $) 1,226
 Net Income (TTM) (Millions $) 28
 Cash Flow (TTM) (Millions $) -145
 Capital Exp. (TTM) (Millions $) 143

Nuvasive Inc
Nuvasive Inc is a medical device company that specializes in surgical solutions for spinal disorders. The company was founded in 1999 and is headquartered in San Diego, California.

Nuvasive's main focus is the development of minimally invasive surgical solutions that can provide better outcomes for patients with spinal disorders. The company's product portfolio includes surgical instruments, spinal implants, and computer systems that help surgeons plan and execute procedures.

Nuvasive's flagship product is the MaXcess line of minimally invasive surgical instruments. These instruments are designed to allow surgeons to perform complex spinal surgeries through small incisions, reducing blood loss and post-operative pain.

In addition to the MaXcess line, Nuvasive offers a range of spinal implants, including interbody cages and pedicle screws. These implants are designed to provide structural support to the spine and encourage new bone growth.

To assist with surgical planning and execution, Nuvasive offers a suite of computer systems. These systems allow surgeons to create 3D models of the patient's spine and plan surgical procedures in advance. During surgery, the systems can provide real-time guidance, helping the surgeon place implants and navigate through the patient's anatomy.

Nuvasive has a strong presence in the United States and Europe, with sales offices and distribution centers in both regions. The company also has a growing presence in Asia, with a focus on China and Japan.

Nuvasive has been recognized for its innovative products and commitment to patient outcomes. The company has received numerous awards for its products, including the Spine Technology Award and the Medical Design Excellence Award.

Overall, Nuvasive is a leading medical device company focused on developing innovative surgical solutions for patients with spinal disorders. The company's unique approach to minimally invasive surgery has attracted a loyal following among top surgeons and healthcare providers around the world.

   Company Address: 12101 Airport Way Broomfield 80021 CO
   Company Phone Number: 455-1476   Stock Exchange / Ticker: NASDAQ NUVA


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Nuvasive Inc

Fiscal Triumph: Nuvasive Inc Reveals Impressive 2.363% Increase Amid 2023's June Closing, Turns EPS from Negative to Positive!

Source: [Insert News Organization]
Nuvasive Inc, a leading Medical Equipment & Supplies company, has reported a significant turnaround in its financial performance for the April to June 30 2023 interval. The company's earnings per share (EPS) improved to $0.14 per share, compared to a loss of $-0.02 per share in the previous year and the prior quarter. This demonstrates a promising trend towards profitability.
In addition to its improved EPS, Nuvasive Inc witnessed a soft revenue growth of 2.363%, reaching $317.79 million in the same quarter, when compared to $310.45 million in the previous year. Sequentially, revenue surged by 3.274% from $307.71 million. This upward trajectory indicates a positive momentum for the company.

Nuvasive Inc

Nuvasive Inc Faces $1.19 Million Tax Charge, Impacting Financial Performance

Nuvasive Inc is a medical technology company headquartered in San Diego, California. The company designs and develops medical devices for surgical applications, with a primary focus on spine surgery. Nuvasive Inc has a significant presence in the global medical equipment and supplies industry, where it competes against other well-established players, such as Medtronic and Johnson & Johnson.
In the first quarter of 2023, Nuvasive Inc reported a return on equity (ROE) of 2.37%, which is below its historical average of 2.7%. The decline in ROE was primarily due to the decrease in net income. Compared to other companies in the medical equipment and supplies industry, Nuvasive Inc's ROE was lower than that of 28 other companies.


Nuvasive Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright Š 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com